Physician profile
Adele A Harrison
NPI 1881052967
$3,594.82
in general payments reported to CMS, 2019-2025
34 companies · $880 in 2025
The $880 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $296 · 2022: $536 · 2023: $972 · 2024: $911 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,762.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $443.41 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $383.75 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $341.80 | 2021-2024 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $286.72 | 2022-2025 | |
| Urogen Pharma, INC. | $213.21 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $199.39 | 2021-2025 | Keytruda, Keytruda Qlex |
| Axonics, INC. | $174.18 | 2022-2023 | Axonics |
| Antares Pharma, INC. | $131.88 | 2021-2025 | Xyosted |
| Accord Healthcare, INC. | $111.49 | 2022-2025 | |
| Tolmar, INC. | $107.74 | 2023-2024 | |
| Myovant Sciences INC. | $107.68 | 2021-2022 | |
| Procept Biorobotics Corporation | $96.20 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $94.94 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $94.61 | 2021-2025 | Provenge |
| Boston Scientific Corporation | $86.06 | 2023-2025 | Ams 700 Cxr Rte Kit, Lithovue, Rezum Generator |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $78.00 | 2024 | |
| Janssen Scientific Affairs, LLC | $71.58 | 2023 | Balversa, Pipeline, Erleada |
| Endo Pharmaceuticals INC. | $63.74 | 2022-2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $51.56 | 2023-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $50.60 | 2021-2022 | |
| Rochester Medical Corporation | $48.72 | 2022 | |
| Astellas Pharma US INC | $47.79 | 2021-2024 | Xtandi |
| Amgen INC. | $45.36 | 2022-2023 | Xgeva |
| Pfizer INC. | $43.72 | 2025 | |
| 180 Medical, INC. | $40.99 | 2021 | |
| Ferring Pharmaceuticals INC. | $31.12 | 2024-2025 | Adstiladrin |
| Immunitybio, INC. | $30.53 | 2025 | |
| Calyxo, INC. | $23.10 | 2025 | Cvac Aspiration System |
| Halozyme INC | $18.58 | 2023 | |
| Blue Earth Diagnostics | $17.59 | 2022 | |
| Verity Pharmaceuticals INC. | $17.58 | 2023 | Trelstar |
| Olympus America INC. | $15.74 | 2023 | Itind System |
| Coloplast Corp | $12.85 | 2021 | |
| Urovant Sciences INC | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adele Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.